U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H25NO5
Molecular Weight 371.4269
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEMECOLCINE

SMILES

CN[C@H]1CCC2=C(C(OC)=C(OC)C(OC)=C2)C3=CC=C(OC)C(=O)C=C13

InChI

InChIKey=NNJPGOLRFBJNIW-HNNXBMFYSA-N
InChI=1S/C21H25NO5/c1-22-15-8-6-12-10-18(25-3)20(26-4)21(27-5)19(12)13-7-9-17(24-2)16(23)11-14(13)15/h7,9-11,15,22H,6,8H2,1-5H3/t15-/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H25NO5
Molecular Weight 371.4269
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/2299625 | https://www.ncbi.nlm.nih.gov/pubmed/25654321 |

Demecolcine, also called Colcemid, was isolated from the autumn crocus in 1950 and commercialized by Ciba. Initially, it was explored as a cancer drug due to its low toxicity. Demecolcine depolymerizes microtubules and limits microtubule formation (inactivates spindle fiber formation), thus arresting cells in metaphase and allowing cell harvest and karyotyping to be performed. Today, it is only used as a research tool mainly to overcome limitations of colchicine due to its very slow association and dissociation rate constants. It binds to tubulin at the same site as colchicine, but ~10-fold faster, and it also dissociates faster. Demecolcine main use has been to arrest cells in mitosis for cytogenetic analysis, though to our knowledge it offers no special advantages over other drugs in this application.

Originator

Sources: Doklady Akademii Nauk UzSSR (1949), (No. 8), 21-5.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: CHEMBL2095182
2.4 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Colcemid

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells.
2004-07-30
Development, chromosomal composition, and cell allocation of bovine cloned blastocyst derived from chemically assisted enucleation and cultured in conditioned media.
2004-06
Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblasts.
2004-05
Relationship between the host cell mitochondria and the parasitophorous vacuole in cells infected with Encephalitozoon microsporidia.
2004-04-08
Asymmetric localization of LGN but not AGS3, two homologs of Drosophila pins, in dividing human neural progenitor cells.
2004-03-15
Detection of mitotic recombination and sex chromosome loss induced by adriamycin, chlorambucil, demecolcine, paclitaxel and vinblastine in somatic cells of Drosophila melanogaster in vivo.
2004-03
Newborn horizontal cells migrate bi-directionally across the neuroepithelium during retinal development.
2004-03
Defective control of mitotic and post-mitotic checkpoints in poly(ADP-ribose) polymerase-1(-/-) fibroblasts after mitotic spindle disruption.
2004-03
Chromosomal analysis of non-small-cell lung cancer by multicolour fluorescent in situ hybridisation.
2004-02-23
CENP-B interacts with CENP-C domains containing Mif2 regions responsible for centromere localization.
2004-02-13
Contribution of noncentrosomal microtubules to spindle assembly in Drosophila spermatocytes.
2004-01
Vertebrate primary cilia: a sensory part of centrosomal complex in tissue cells, but a "sleeping beauty" in cultured cells?
2004
Brush-like fibers on the human chromosome periphery.
2003-12-31
Cell cycle checkpoint function in bladder cancer.
2003-12-17
X-irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin-dependent apoptosis.
2003-12
Simultaneous binding of two different drugs in the binding pocket of the human multidrug resistance P-glycoprotein.
2003-10-10
The ATP-dependent helicase RUVBL1/TIP49a associates with tubulin during mitosis.
2003-10
Premature chromosome condensation revisited: a novel chemical approach permits efficient cytogenetic analysis of cancers.
2003-10
The interrelationship between DRIM gene expression and cytogenetic and phenotypic characteristics in human breast tumor cell lines.
2003-09-22
The role of PAR-1 in regulating the polarised microtubule cytoskeleton in the Drosophila follicular epithelium.
2003-09
Differential effects of vitamin E and three hydrophilic antioxidants on the actinomycin D-induced and colcemid-accelerated apoptosis in human leukemia CMK-7 cell line.
2003-08
Delayed arteriolar relaxation after prolonged agonist exposure: functional remodeling involving tyrosine phosphorylation.
2003-08
S-adenosyl-L-methionine is able to reverse micronucleus formation induced by sodium arsenite and other cytoskeleton disrupting agents in cultured human cells.
2003-07-25
Mutations in alpha- and beta-tubulin that stabilize microtubules and confer resistance to colcemid and vinblastine.
2003-07
Possible associations between ELF electromagnetic fields, DNA damage response processes and childhood leukaemia.
2003-06-16
Permanent activation of the human P-glycoprotein by covalent modification of a residue in the drug-binding site.
2003-06-06
The rat STSL locus: characterization, chromosomal assignment, and genetic variations in sitosterolemic hypertensive rats.
2003-06-03
Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules.
2003-05-16
Substrate-induced conformational changes in the transmembrane segments of human P-glycoprotein. Direct evidence for the substrate-induced fit mechanism for drug binding.
2003-04-18
Octaploid Meth-A cells are established from a highly polyploidized cell population.
2003-04
Cloned mice derived from embryonic stem cell karyoplasts and activated cytoplasts prepared by induced enucleation.
2003-04
Demecolcine-induced oocyte enucleation for somatic cell cloning: coordination between cell-cycle egress, kinetics of cortical cytoskeletal interactions, and second polar body extrusion.
2003-04
Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells.
2003-02-24
Involvement of the nonhomologous end joining DNA repair pathway in the bystander effect for chromosomal aberrations.
2003-02
ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells.
2003-01-18
Drug binding in human P-glycoprotein causes conformational changes in both nucleotide-binding domains.
2003-01-17
Bacteriocyte population growth in Blattella germanica.
2003-01
Different apoptotic responses and patterns in adhering and floating neoplastic cell cultures: effects of microtubule antagonists.
2003-01
Effect of demecolcine and nocodazole on the efficiency of chemically assisted removal of chromosomes and the developmental potential of nuclear transferred porcine oocytes.
2003
Production of cloned pigs by using somatic cells as donors.
2003
Spontaneous chromosome loss and colcemid resistance in lymphocytes from patients with myotonic dystrophy type 1.
2003
Beta class II tubulin predominates in normal and tumor breast tissues.
2003
Assays for neoplastic cell enrichment in bone marrow samples.
2003
In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation.
2002-12-16
Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition.
2002-12-02
Effects of polyphenolic anthrone derivatives, resistomycin and hypercin, on apoptosis in human megakaryoblastic leukemia CMK-7 cell line.
2002-11-21
Binding of hsp90-associated immunophilins to cytoplasmic dynein: direct binding and in vivo evidence that the peptidylprolyl isomerase domain is a dynein interaction domain.
2002-11-19
Effect of delayed enucleation on the developmental potential of nuclear-transferred oocytes receiving adult and fetal fibroblast cells.
2002-08
CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
2002-04
Functional inactivation of pRB results in aneuploid mammalian cells after release from a mitotic block.
2002-03-18
Patents

Sample Use Guides

sheep were treated with Demecolcine at doses 0.22, 0.30, 0.35, and 0.65 mg/kg body weight
Route of Administration: Intravenous
The human U251 glioblastoma cell line was used for activity evaluation. U251 cells were seeded at 200 000 cells per 35 mm dish 1 day prior to addition of test compounds (Demecolcine). Cell cycle analyses were performed 24 h after addition of test compounds (Demecolcine, 3 μM), using a Guava Personal Cytometer (EMD Millipore) according to the manufacturer’s protocol for the Guava Cell Cycle Reagent. CytoSoft 2.1.4 software was used to analyze the resulting DNA histograms and calculate the percentage of cells in each phase of the cell cycle, based on a total of 5000 events per sample
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:35:01 GMT 2025
Edited
by admin
on Mon Mar 31 18:35:01 GMT 2025
Record UNII
Z01IVE25KI
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
C-12669
Preferred Name English
DEMECOLCINE
INN   MI   WHO-DD  
INN  
Official Name English
demecolcine [INN]
Common Name English
DEACETYL-N-METHYLCOLCHICINE
Common Name English
DEMECOLCINE [MI]
Common Name English
NSC-3096
Code English
Demecolcine [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC L01CC01
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
WHO-VATC QL01CC01
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
NCI_THESAURUS C67421
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
Code System Code Type Description
EPA CompTox
DTXSID7020342
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
NSC
3096
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
CHEBI
4393
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
DRUG BANK
DB13318
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
SMS_ID
100000083691
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
MESH
D003703
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
DRUG CENTRAL
4375
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
NCI_THESAURUS
C419
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
CAS
477-30-5
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
INN
509
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
PUBCHEM
220401
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
FDA UNII
Z01IVE25KI
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
MERCK INDEX
m4161
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY Merck Index
ChEMBL
CHEMBL433632
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
WIKIPEDIA
DEMECOLCINE
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
EVMPD
SUB06964MIG
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
ECHA (EC/EINECS)
207-514-6
Created by admin on Mon Mar 31 18:35:01 GMT 2025 , Edited by admin on Mon Mar 31 18:35:01 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY